{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:18:49Z","timestamp":1792095529854,"version":"4.4.0"},"reference-count":40,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>The increasing availability of treatments and the importance of early intervention have stimulated interest in newborn screening for lysosomal storage diseases. Since 2015, 112,446 newborns in North Eastern Italy have been screened for four lysosomal disorders\u2014mucopolysaccharidosis type I and Pompe, Fabry and Gaucher diseases\u2014using a multiplexed tandem mass spectrometry (MS\/MS) assay system. We recalled 138 neonates (0.12%) for collection of a second dried blood spot. Low activity was confirmed in 62 (0.06%), who underwent confirmatory testing. Twenty-five neonates (0.02%) were true positive: eight with Pompe disease; seven with Gaucher disease; eight with Fabry disease; and two with Mucopolysaccharidosis type I. The combined incidence of the four disorders was 1 in 4497 births. Except for Pompe disease, a second-tier test was implemented. We conclude that newborn screening for multiple lysosomal storage diseases combined with a second-tier test can largely eliminate false-positives and achieve rapid diagnosis.<\/jats:p>","DOI":"10.3390\/ijns5020024","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T11:54:31Z","timestamp":1561118071000},"page":"24","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-137X","authenticated-orcid":false,"given":"Alberto B.","family":"Burlina","sequence":"first","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Regional Center for Expanded Neonatal Screening, Department of Women and Children\u2019s Health, University Hospital of Padova, Via Orus 2\/B, 35129 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3157-2979","authenticated-orcid":false,"given":"Giulia","family":"Polo","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Regional Center for Expanded Neonatal Screening, Department of Women and Children\u2019s Health, University Hospital of Padova, Via Orus 2\/B, 35129 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rubert","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Regional Center for Expanded Neonatal Screening, Department of Women and Children\u2019s Health, University Hospital of Padova, Via Orus 2\/B, 35129 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gueraldi","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Regional Center for Expanded Neonatal Screening, Department of Women and Children\u2019s Health, University Hospital of Padova, Via Orus 2\/B, 35129 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cazzorla","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Regional Center for Expanded Neonatal Screening, Department of Women and Children\u2019s Health, University Hospital of Padova, Via Orus 2\/B, 35129 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Duro","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council, Via Ugo La Malfa, 153-90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Salviati","sequence":"additional","affiliation":[{"name":"Clinical Genetics Unit, Department of Women\u2019s and Children\u2019s Health, University of Padova, Via Giustiniani 3, 35128 Padova, Italy"},{"name":"IRP Citt\u00e0 della Speranza, Corso Stati Uniti 4, 35129 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-4706","authenticated-orcid":false,"given":"Alessandro P.","family":"Burlina","sequence":"additional","affiliation":[{"name":"Neurological Unit, St. Bassiano Hospital, Via dei Lotti 40, 36061 Bassano del Grappa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gelb, M.H., Lukacs, Z., Ranieri, E., and Schielen, P.C.J.I. (2019). Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5010001"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2014.225771","article-title":"Newborn screening for lysosomal storage diseases","volume":"61","author":"Gelb","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/clinchem\/47.4.780","article-title":"Diagnosis of \u03b1-l-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis","volume":"47","author":"Chamoles","year":"2001","journal-title":"Clin. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10545-006-0265-4","article-title":"Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders","volume":"29","author":"Gelb","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1373\/clinchem.2011.163139","article-title":"Digital Microfluidic Platform for Multiplexing Enzyme Assays: Implications for Lysosomal Storage Disease Screening in Newborns","volume":"57","author":"Sista","year":"2011","journal-title":"Clin. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: Results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for fabry disease in Taiwan reveals a high incidence of the later-onset mutation c.936+919G>A (IVS4+919G>A)","volume":"30","author":"Hwu","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pediatrneurol.2008.11.010","article-title":"Newborn screening for Krabbe disease: The New York State model","volume":"40","author":"Duffner","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","article-title":"Neonatal screening for lysosomal storage disorders: Feasibility and incidence from a nationwide study in Austria","volume":"379","author":"Mechtler","year":"2012","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: Findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn screening for lysosomal storage disorders in Illinois: The initial 15-month experience","volume":"190","author":"Burton","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","article-title":"Pilot study of newborn screening for six lysosomal storage diseases using tandem mass spectrometry","volume":"118","author":"Elliott","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: Report of the first 65,000 infants","volume":"21","author":"Wasserstein","year":"2018","journal-title":"Genet. Med."},{"key":"ref_15","unstructured":"(2019, March 27). US Department of Health and Human Services Secretary\u2019s Advisory Committee on Heritable Disorders in Newborns and Children, Available online: https:\/\/www.hrsa.gov\/advisory-committees\/heritable-disorders\/rusp\/index.html."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","article-title":"Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy","volume":"41","author":"Burlina","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Polo, G., Burlina, A.P., Ranieri, E., Colucci, F., Rubert, L., Pascarella, A., Duro, G., Tummolo, A., Padoan, A., and Plebani, M. (2019). Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: A comparative study. Clin. Chem. Lab. Med.","DOI":"10.1515\/cclm-2018-1301"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3343\/alm.2013.33.4.274","article-title":"Analysis of lyso-globotriaosylsphingosine in dried blood spots","volume":"33","author":"Johnson","year":"2013","journal-title":"Ann. Lab. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ymgme.2012.09.024","article-title":"Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III","volume":"107","author":"Wagemans","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_20","unstructured":"(2019, May 17). Regione Veneto, Health Department. Available online: https:\/\/bur.regione.veneto.it\/BurvServices\/pubblica\/DettaglioDgr.aspx?id=254110."},{"key":"ref_21","unstructured":"(2019, May 17). Regione Friuli Venezia Giulia, Health Department. Available online: http:\/\/mtom.regione.fvg.it\/storage\/\/2016_74\/Testo integrale della Delibera n 74-2016.pdf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by Isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/48.1.131","article-title":"Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry","volume":"48","author":"Rozaklis","year":"2002","journal-title":"Clin. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: A new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2010.09.003","article-title":"Efficient analysis of urinary glycosaminoglycans by LC-MS\/MS in mucopolysaccharidoses type I, II and VI","volume":"102","author":"Bherer","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.gene.2015.02.023","article-title":"Novel GAA mutations in patients with Pompe disease","volume":"561","author":"Turaca","year":"2015","journal-title":"Gene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nmd.2006.09.004","article-title":"Pompe disease (glycogen storage disease type II) in Argentineans: Clinical manifestations and identification of 9 novel mutations","volume":"17","author":"Palmer","year":"2007","journal-title":"Neuromuscul Disord."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Tebani, A., Zanoutene-Cheriet, L., Adjtoutah, Z., Abily-Donval, L., Brasse-Lagnel, C., Laquerri\u00e8re, A., Marret, S., Benabdellah, A.C., Bekri, S., and Tikkanen, R. (2016). Clinical and molecular characterization of patients with mucopolysaccharidosis type I in an algerian series. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050743"},{"key":"ref_29","first-page":"759","article-title":"Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships","volume":"10","author":"Bay","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/humu.9058","article-title":"Analysis of the glucocerebrosidase gene and mutationprofile in 144 Italiangaucherpatients","volume":"20","author":"Filocamo","year":"2002","journal-title":"Hum. Mutat."},{"key":"ref_31","unstructured":"(2019, March 27). International Fabry Disease Genotype-Phenotype Database (dbFGP). Available online: http:\/\/www.dbfgp.org\/dbFgp\/fabry\/FabryGP.html."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1067\/mpd.2002.122394","article-title":"Inborn errors of metabolism in the Italian pediatric population: A national retrospective survey","volume":"140","author":"Rizzo","year":"2002","journal-title":"J. Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13052-018-0552-3","article-title":"Newborn screening in mucopolysaccharidoses","volume":"44","author":"Donati","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gelb, M.H. (2018). Newborn screening for lysosomal storage diseases: Methodologies, screen positive rates, normalization of datasets, second-tier tests, and post-analysis tools. Int. J. Neonatal Screen., 4.","DOI":"10.3390\/ijns4030023"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pettazzoni, M., Froissart, R., Pagan, C., Vanier, M.T., Ruet, S., Latour, P., Guffon, N., Fouilhoux, A., Germain, D.P., and Levade, T. (2017). LC-MS\/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181700"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease","volume":"52","author":"Smid","year":"2015","journal-title":"J. Med. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13052-016-0320-1","article-title":"Metabolic progression to clinical phenotype in classic Fabry disease","volume":"43","author":"Spada","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10545-012-9547-1","article-title":"Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation","volume":"36","author":"Chien","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2016.12.010","article-title":"Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10897-017-0139-y","article-title":"The psychosocial impact of carrying a debated variant in the GLA gene","volume":"27","author":"Macklin","year":"2018","journal-title":"J. Genet. Couns."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/5\/2\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:00:20Z","timestamp":1760187620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/5\/2\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["ijns5020024"],"URL":"https:\/\/doi.org\/10.3390\/ijns5020024","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]}}}